Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Dec 17, 2019 at 9:14 AM EST

This Is How to Protect Yourself Against the Flu, According to Doctors

The influenza season officially runs from October to as late as May each year. Activity peaks around the end of…

Chris Lange | Dec 17, 2019 at 9:10 AM EST

Will This Dementia Treatment Be a Big Hit After FDA Decision?

Prevail Therapeutics shares jumped early on Tuesday after the firm announced that the FDA has granted Orphan Drug designation for…

Jon C. Ogg | Dec 16, 2019 at 10:55 AM EST

Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020

Goldman Sachs believes that several health care companies can win, and it has three top picks for 2020 that may…

Chris Lange | Dec 13, 2019 at 10:10 AM EST

Sarepta Catches a Big Break With Duchenne Muscular Dystrophy Drug

Sarepta shares jumped on Friday after the firm announced that the FDA has approved Vyondys 53 (golodirsen) for the treatment…

Jon C. Ogg | Dec 13, 2019 at 9:55 AM EST

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Independent research firm Argus sees better than 25% potential upside for Bristol-Myers Squibb in the coming year.

Chris Lange | Dec 12, 2019 at 12:05 PM EST

Wedbush’s Top Picks After ASH Annual Meeting

The American Society of Hematology (ASH) hosted its 61st annual meeting and one of the biggest biotech events earlier this…

Chris Lange | Dec 12, 2019 at 9:15 AM EST

Why These Breast Cancer Study Results Look So Promising

Puma Biotechnology shares made a handy gain early on Thursday after the company presented updated results from its Phase 2…

Chris Lange | Dec 11, 2019 at 12:20 PM EST

Is This Atrial Fibrillation Drug Done For After FDA Vote?

Correvio Pharma shares were crushed after the firm announced the FDA Cardiovascular and Renal Drugs Advisory Committee decision for its…

Chris Lange | Dec 11, 2019 at 11:10 AM EST

Why This Cystic Fibrosis Study Is Getting a Big Boost

Proteostasis shares jumped on Wednesday after the firm announced positive, initial ex-vivo results of its proprietary cystic fibrosis transmembrane conductance…

Chris Lange | Dec 11, 2019 at 9:45 AM EST

Big Pharma Short Sellers Grow More Selective

The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Dec 11, 2019 at 9:10 AM EST

Major Biotechs See a Rising Tide in Short Interest

The November 29 short interest data has been compared with the previous report, and short interest in most of these…

Paul Ausick | Dec 10, 2019 at 12:00 PM EST

Health Insurance Helps You Live Longer

A new study indicates that the individual mandate portion of the Affordable Care Act (Obamacare) did encourage more people to…

Chris Lange | Dec 10, 2019 at 10:10 AM EST

Will This FDA Decision Set Off These Late-Stage Dermatitis Studies?

Dermira shares jumped on Tuesday after the firm announced that the FDA has granted Fast Track designation for lebrikizumab, its…

Douglas A. McIntyre | Dec 10, 2019 at 7:00 AM EST

More Americans Delay Medical Treatment Because of Cost

Some sick Americans have probably become sicker because they do not believe they can pay for appropriate treatment. And the…

Chris Lange | Dec 9, 2019 at 11:50 AM EST

Why Fate Therapeutics Is One of ASH’s Biggest Winners

Fate Therapeutics shares jumped on Monday after the firm announced new preclinical data for its off-the-shelf, multi-antigen targeting natural killer…

1 … 75 76 77 78 79 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

This Is How to Protect Yourself Against the Flu, According to Doctors

Will This Dementia Treatment Be a Big Hit After FDA Decision?

Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020

Sarepta Catches a Big Break With Duchenne Muscular Dystrophy Drug

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Wedbush’s Top Picks After ASH Annual Meeting

Why These Breast Cancer Study Results Look So Promising

Is This Atrial Fibrillation Drug Done For After FDA Vote?

Why This Cystic Fibrosis Study Is Getting a Big Boost

Big Pharma Short Sellers Grow More Selective

Major Biotechs See a Rising Tide in Short Interest

Health Insurance Helps You Live Longer

Will This FDA Decision Set Off These Late-Stage Dermatitis Studies?

More Americans Delay Medical Treatment Because of Cost

Why Fate Therapeutics Is One of ASH’s Biggest Winners

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

This Is How to Protect Yourself Against the Flu, According to Doctors

Will This Dementia Treatment Be a Big Hit After FDA Decision?

Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020

Sarepta Catches a Big Break With Duchenne Muscular Dystrophy Drug

Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020

Wedbush’s Top Picks After ASH Annual Meeting

Why These Breast Cancer Study Results Look So Promising

Is This Atrial Fibrillation Drug Done For After FDA Vote?

Why This Cystic Fibrosis Study Is Getting a Big Boost

Big Pharma Short Sellers Grow More Selective

Major Biotechs See a Rising Tide in Short Interest

Health Insurance Helps You Live Longer

Will This FDA Decision Set Off These Late-Stage Dermatitis Studies?

More Americans Delay Medical Treatment Because of Cost

Why Fate Therapeutics Is One of ASH’s Biggest Winners

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up